Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-041946
Filing Date
2025-03-19
Accepted
2025-03-19 15:03:42
Documents
1
Period of Report
2025-03-17

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3987
  Complete submission text file 0000950170-25-041946.txt   5370
Mailing Address 5217 WINNEBAGO LANE AUSTIN TX 78744
Business Address 5217 WINNEBAGO LANE AUSTIN TX 78744 512-386-2900
XBiotech Inc. (Issuer) CIK: 0001626878 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 8201 E RIVERSIDE DRIVE BLDG 4, STE 100 AUSTIN TX 78744
Business Address
SIMARD JOHN (Reporting) CIK: 0001639078 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37347 | Film No.: 25752234